The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier

Vasoactive intestinal peptide (VIP) plays an important role in the neuro-endocrine-immune system. Mast cells (MCs) are important immune effector cells. This study was conducted to investigate the protective effect of L. casei ATCC 393 on Enterotoxigenic Escherichia coli (ETEC) K88-induced intestinal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaofan Song, Shanyao Pi, Yueming Gao, Fengxia Zhou, Shuqi Yan, Yue Chen, Lei Qiao, Xina Dou, Dongyan Shao, Chunlan Xu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/83d03abbe3764ede81b422d1c143f50c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83d03abbe3764ede81b422d1c143f50c
record_format dspace
spelling oai:doaj.org-article:83d03abbe3764ede81b422d1c143f50c2021-12-01T03:00:21ZThe Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier1664-322410.3389/fimmu.2021.723173https://doaj.org/article/83d03abbe3764ede81b422d1c143f50c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.723173/fullhttps://doaj.org/toc/1664-3224Vasoactive intestinal peptide (VIP) plays an important role in the neuro-endocrine-immune system. Mast cells (MCs) are important immune effector cells. This study was conducted to investigate the protective effect of L. casei ATCC 393 on Enterotoxigenic Escherichia coli (ETEC) K88-induced intestinal mucosal immune barrier injury and its association with VIP/MC signaling by in vitro experiments in cultures of porcine mucosal mast cells (PMMCs) and in vivo experiments using VIP receptor antagonist (aVIP) drug. The results showed that compared with the ETEC K88 and lipopolysaccharides (LPS)-induced model groups, VIP pretreatment significantly inhibited the activation of MCs and the release of β-hexosaminidase (β-hex), histamine and tryptase. Pretreatment with aVIP abolished the protective effect of L. casei ATCC 393 on ETEC K88-induced intestinal mucosal immune barrier dysfunction in C57BL/6 mice. Also, with the blocking of VIP signal transduction, the ETEC K88 infection increased serum inflammatory cytokines, and the numbers of degranulated MCs in ileum, which were decreased by administration of L. casei ATCC 393. In addition, VIP mediated the regulatory effect of L. casei ATCC 393 on intestinal microbiota in mice. These findings suggested that VIP may mediate the protective effect of L.casei ATCC 393 on intestinal mucosal immune barrier dysfunction via MCs.Xiaofan SongShanyao PiYueming GaoFengxia ZhouShuqi YanYue ChenLei QiaoXina DouDongyan ShaoChunlan XuFrontiers Media S.A.articleprobioticLactobacillus casei ATCC 393mast cellsvasoactive intestinal peptidemucosal immuneintestinal barrierImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic probiotic
Lactobacillus casei ATCC 393
mast cells
vasoactive intestinal peptide
mucosal immune
intestinal barrier
Immunologic diseases. Allergy
RC581-607
spellingShingle probiotic
Lactobacillus casei ATCC 393
mast cells
vasoactive intestinal peptide
mucosal immune
intestinal barrier
Immunologic diseases. Allergy
RC581-607
Xiaofan Song
Shanyao Pi
Yueming Gao
Fengxia Zhou
Shuqi Yan
Yue Chen
Lei Qiao
Xina Dou
Dongyan Shao
Chunlan Xu
The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier
description Vasoactive intestinal peptide (VIP) plays an important role in the neuro-endocrine-immune system. Mast cells (MCs) are important immune effector cells. This study was conducted to investigate the protective effect of L. casei ATCC 393 on Enterotoxigenic Escherichia coli (ETEC) K88-induced intestinal mucosal immune barrier injury and its association with VIP/MC signaling by in vitro experiments in cultures of porcine mucosal mast cells (PMMCs) and in vivo experiments using VIP receptor antagonist (aVIP) drug. The results showed that compared with the ETEC K88 and lipopolysaccharides (LPS)-induced model groups, VIP pretreatment significantly inhibited the activation of MCs and the release of β-hexosaminidase (β-hex), histamine and tryptase. Pretreatment with aVIP abolished the protective effect of L. casei ATCC 393 on ETEC K88-induced intestinal mucosal immune barrier dysfunction in C57BL/6 mice. Also, with the blocking of VIP signal transduction, the ETEC K88 infection increased serum inflammatory cytokines, and the numbers of degranulated MCs in ileum, which were decreased by administration of L. casei ATCC 393. In addition, VIP mediated the regulatory effect of L. casei ATCC 393 on intestinal microbiota in mice. These findings suggested that VIP may mediate the protective effect of L.casei ATCC 393 on intestinal mucosal immune barrier dysfunction via MCs.
format article
author Xiaofan Song
Shanyao Pi
Yueming Gao
Fengxia Zhou
Shuqi Yan
Yue Chen
Lei Qiao
Xina Dou
Dongyan Shao
Chunlan Xu
author_facet Xiaofan Song
Shanyao Pi
Yueming Gao
Fengxia Zhou
Shuqi Yan
Yue Chen
Lei Qiao
Xina Dou
Dongyan Shao
Chunlan Xu
author_sort Xiaofan Song
title The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier
title_short The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier
title_full The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier
title_fullStr The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier
title_full_unstemmed The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier
title_sort role of vasoactive intestinal peptide and mast cells in the regulatory effect of lactobacillus casei atcc 393 on intestinal mucosal immune barrier
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/83d03abbe3764ede81b422d1c143f50c
work_keys_str_mv AT xiaofansong theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT shanyaopi theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT yueminggao theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT fengxiazhou theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT shuqiyan theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT yuechen theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT leiqiao theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT xinadou theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT dongyanshao theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT chunlanxu theroleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT xiaofansong roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT shanyaopi roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT yueminggao roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT fengxiazhou roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT shuqiyan roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT yuechen roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT leiqiao roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT xinadou roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT dongyanshao roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
AT chunlanxu roleofvasoactiveintestinalpeptideandmastcellsintheregulatoryeffectoflactobacilluscaseiatcc393onintestinalmucosalimmunebarrier
_version_ 1718405913178537984